Clinical outcomes of contezolid in treating complex tuberculosis: real-world evidence from 11 patients. [PDF]
Liu Y, Cui Z, Fu Y, Chan ED, Hu C.
europepmc +1 more source
Can we escape from top-priority ESKAPE pathogens? [PDF]
Zeng L, Feng Y, Wang M.
europepmc +1 more source
Clinical Features and Treatment Differences Among Tuberculous, Brucellosis, and Pyogenic Spondylitis: A Cohort Study. [PDF]
Shen JJ +5 more
europepmc +1 more source
Novel Oxazolidinone Derivatives Containing Quaternary Ammonium Fragments with Potent Antibacterial Potency. [PDF]
Zheng C +11 more
europepmc +1 more source
<i>In Vitro</i> Activity of Sulfamethoxazole-Trimethoprim, Amikacin, Oxazolidinones, Fluoroquinolones and Fidaxomicin against Isolates of <i>Nocardia</i>. [PDF]
Wang C +11 more
europepmc +1 more source
β-tricalcium phosphate/calcium sulfate loaded with contezolid acefosamil (MRX-4) for antimicrobial potency, prevention and killing efficacy of MRSA biofilm. [PDF]
Jiang N +8 more
europepmc +1 more source
Efficacy of Contezolid in the Treatment of Catheter-Related Bloodstream Infections Caused by Methicillin-Resistant Staphylococcus aureus in a Patient with Hepatorenal Syndrome and Acute Kidney Injury: A Case Report. [PDF]
Zhang X, Huang H, Wang J, Wei B.
europepmc +1 more source
Sequential Therapy of Linezolid and Contezolid to Treat Hematogenous Lung Abscess Caused by Staphylococcus aureus in a Congenital Cerebral Hypoplasia Patient: A Case Report. [PDF]
Zhou S, Xin C, Liu W.
europepmc +1 more source
Triple antimicrobial combinations with potent synergistic activity against <i>M. abscessus</i>. [PDF]
Huang Y +3 more
europepmc +1 more source

